CU Anschutz Innovations Annual Report 2026
Showcasing a Year of Innovations
We guide faculty innovators in turning breakthrough research into meaningful advances for patients. This year’s report highlights progress in data-driven cancer research, innovative medical technologies, commercialization support and strategic partnerships that help move discoveries forward. Featured innovations and companies include RefinedScience, Parley Neurotech, SpyGlass Pharma, Renovare Therapeutics and Foresight Diagnostics.
Our Mission and Services
CU Anschutz Innovations specializes in commercializing technology, developing ventures, and building business partnerships. Located on the University of Colorado, we are the go-to resource for biomedical technology commercialization. By uniting industry partners, entrepreneurs, and investors, we assist CU researchers in developing biomedical technologies - improving the quality of life for patients worldwide.